Fig. 1From: Pharmacist-driven outreach initiative to increase prescribing of sodium-glucose cotransporter-2 inhibitors in eligible VHA patients with chronic kidney disease: a study protocolCare processes and analysis of study arms. *Analyses will include all patients identified in the VA dashboardBack to article page